Diamandis, Eleftherios P.

Novel therapeutic applications of cardiac glycosides

Prassas, I., & Diamandis, E. P. (2008) · Nature Reviews Drug Discovery

Ion Transport and Channel RegulationPhytochemistry and Bioactive Compounds

Cited by 673

Cancer-Associated Fibroblasts Drive the Progression of Metastasis through both Paracrine and Mechanical Pressure on Cancer Tissue

Karagiannis, G. S., Poutahidis, T., Erdman, S. E., Kirsch, R., Riddell, R. H., & Diamandis, E. P. (2012) · Molecular Cancer Research

Cancer Cells and MetastasisCellular Mechanics and Interactions

Cited by 507

The cancer cell secretome: A good source for discovering biomarkers?

Pavlou, M. P., & Diamandis, E. P. (2010) · Journal of Proteomics

Advanced Proteomics Techniques and ApplicationsProtease and Inhibitor Mechanisms

Cited by 200

NONPROSTATIC SOURCES OF PROSTATE-SPECIFIC ANTIGEN

Diamandis, E. P., & Yu, H. (1997) · Urologic Clinics of North America

Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and Treatment

Cited by 172

Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer’s disease patients and controls

Martínez-Morillo, E., Hansson, O., Atagi, Y., Bu, G., Minthon, L., Diamandis, E. P., & Nielsen, H. M. (2014) · Acta Neuropathologica

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 168

Prostate specific antigen in breast cancer, benign breast disease and normal breast tissue

Yu, H., Diamandis, E. P., Levesque, M., Giai, M., Roagna, R., Ponzone, R., Sismondi, P., Monne, M., & Croce, C. M. (1996) · Breast Cancer Research and Treatment

Breast Lesions and CarcinomasBreast Cancer Treatment Studies

Cited by 106

Brain-related proteins as potential CSF biomarkers of Alzheimer's disease: A targeted mass spectrometry approach

Begcevic, I., Brinc, D., Brown, M., Martinez-Morillo, E., Goldhardt, O., Grimmer, T., Magdolen, V., Batruch, I., & Diamandis, E. P. (2018) · Journal of Proteomics

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 81

Prostate-Specific Antigen in Female Serum, a Potential New Marker of Androgen Excess

Melegos, D. N., Yu, H., Ashok, M., Wang, C., Stanczyk, F., & Diamandis, E. P. (1997) · The Journal of Clinical Endocrinology & Metabolism

Ovarian function and disordersHormonal and reproductive studies

Cited by 78

False Biomarker Discovery due to Reactivity of a Commercial ELISA for CUZD1 with Cancer Antigen CA125

Prassas, I., Brinc, D., Farkona, S., Leung, F., Dimitromanolakis, A., Chrystoja, C. C., Brand, R., Kulasingam, V., Blasutig, I. M., & Diamandis, E. P. (2014) · Clinical Chemistry

Pancreatic and Hepatic Oncology ResearchClinical Laboratory Practices and Quality Control

Cited by 52

Neuronal pentraxin receptor-1 is a new cerebrospinal fluid biomarker of Alzheimer’s disease progression

Begcevic, I., Tsolaki, M., Brinc, D., Brown, M., Martinez-Morillo, E., Lazarou, I., Kozori, M., Tagaraki, F., Nenopoulou, S., Gkioka, M., et al. (2018) · F1000Research

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 51

Direct measurement of serum free testosterone by ultrafiltration followed by liquid chromatography tandem mass spectrometry

Chen, Y., Yazdanpanah, M., Wang, X. Y., Hoffman, B. R., Diamandis, E. P., & Wong, P.-Y. (2010) · Clinical Biochemistry

Hormonal and reproductive studiesClinical Laboratory Practices and Quality Control

Cited by 43

Multi-omics Biomarker Pipeline Reveals Elevated Levels of Protein-glutamine Gamma-glutamyltransferase 4 in Seminal Plasma of Prostate Cancer Patients

Drabovich, A. P., Saraon, P., Drabovich, M., Karakosta, T. D., Dimitromanolakis, A., Hyndman, M. E., Jarvi, K., & Diamandis, E. P. (2019) · Molecular & Cellular Proteomics

Prostate Cancer Diagnosis and TreatmentProstate Cancer Treatment and Research

Cited by 40

Cerebrospinal fluid neuronal pentraxin receptor as a biomarker of long-term progression of Alzheimer’s disease: A 24-month follow-up study

Lim, B., Sando, S. B., Grøntvedt, G. R., Bråthen, G., & Diamandis, E. P. (2020) · Neurobiology of Aging

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 39

Accuracy of Testosterone Concentrations in Compounded Testosterone Products

Grober, E. D., Garbens, A., Božović, A., Kulasingam, V., Fanipour, M., & Diamandis, E. P. (2015) · The Journal of Sexual Medicine

Hormonal and reproductive studiesPharmacy and Medical Practices

Cited by 27

Liquid biopsy of cerebrospinal fluid identifies neuronal pentraxin receptor (NPTXR) as a biomarker of progression of Alzheimer’s disease

Lim, B., Tsolaki, M., Soosaipillai, A., Brown, M., Zilakaki, M., Tagaraki, F., Fotiou, D., Koutsouraki, E., Grosi, E., Prassas, I., et al. (2019) · Clinical Chemistry and Laboratory Medicine (CCLM)

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 25

Decreased cerebrospinal fluid neuronal pentraxin receptor is associated with PET-Aβ load and cerebrospinal fluid Aβ in a pilot study of Alzheimer’s disease

Lim, B., Fowler, C., Li, Q.-X., Rowe, C., Dhiman, K., Gupta, V. B., Masters, C. L., Doecke, J. D., Martins, R. N., Collins, S., et al. (2020) · Neuroscience Letters

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 10